Affordable Access

deepdyve-link
Publisher Website

The use of bumetanide for oliguric acute renal failure in preterm infants.

Authors
  • Oliveros, Milette
  • Pham, Jennifer T
  • John, Eunice
  • Resheidat, Ashraf
  • Bhat, Rama
Type
Published Article
Journal
Pediatric Critical Care Medicine
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Mar 01, 2011
Volume
12
Issue
2
Pages
210–214
Identifiers
DOI: 10.1097/PCC.0b013e3181e912a7
PMID: 20625335
Source
Medline
License
Unknown

Abstract

Bumetanide therapy significantly increased urine output within 24-48 hrs, but its use was associated with a transient increase in serum creatinine level. Bumetanide can be used in preterm infants to reverse oliguria when therapy with furosemide fails. Prospective, randomized, controlled trials with long-term follow-up in preterm infants are necessary to establish the usefulness of bumetanide for OARF.

Report this publication

Statistics

Seen <100 times